.Merck & Co.'s TIGIT course has actually suffered another misfortune. Months after shuttering a p...
.After a year described by pipeline hairstyles, the shift of its own CEO and also discharges, Exscie...
.Cullinan Therapy was actually blown away enough along with Harbour BioMed's bispecific immune syste...
.In this week's episode of "The Leading Line," our team are actually diving right into Brutal Biotec...
.The confetti is still soaring coming from Eli Lilly's event celebrating the commendation of Alzheim...
.Accept to recently's Chutes & Ladders, our summary of significant leadership hirings, firings an...
.Adhering to a poor revealing for Lykos Therapies' MDMA candidate for post-traumatic stress disorder...
.AN2 Therapeutics is actually reconsidering its own organization in reaction to uninspired midphase ...
.Merck & Co. is spending $700 thousand upfront to test Amgen in a blood cancer market. The bargai...
.With Gilead Sciences almost an FDA selection for its own liver ailment drug seladelpar, the busines...